Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of California At Davis |
| Country | United States |
| Start Date | May 01, 2024 |
| End Date | Apr 30, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10882601 |
Project Summary/Abstract We and others showed that ferredoxin reductase (FDXR), a mitochondrial flavoprotein, is induced by DNA damage in a p53-dependent manner and regulates apoptosis induced by reactive oxygen species. As the only human ferredoxin reductase, FDXR receives two electrons from NADPH and transfers them
one at a time to its cognate substrates ferredoxin 1 (FDX1) and FDX2 and subsequently, plays a role in biogenesis of steroids and iron sulfur cluster proteins. Despite these well-defined biochemical functions, the role of FDXR in tumor suppression is still poorly understood. Interestingly, recent studies
showed that FDXR is the most consistent acute sensor following DNA damage, suggesting that FDXR plays a role in DNA damage response and repair. Indeed, our pilot studies showed that FDXR is also expressed in the nucleus and regulates cell growth and survival potentially via its nuclear substrates (p53, Mdm2, and Mdm4) in response to a stress. These observations prompt us to hypothesize that the
nuclear FDXR has a critical biological function in tumor suppression. To further test this, two specific aims are proposed: (1) To determine how FDXR subcellular localization is regulated; (2) To determine how the nuclear FDXR exerts its biological function.
University of California At Davis
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant